Page last updated: 2024-10-21

2-fluorohexadecanoic acid and Glioblastoma

2-fluorohexadecanoic acid has been researched along with Glioblastoma in 1 studies

2-fluorohexadecanoic acid: inhibits sphingosine base formation & accumulates in membrane lipids of cultured mammalian cells

Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jiapaer, S1
Furuta, T1
Dong, Y1
Kitabayashi, T1
Sabit, H1
Zhang, J1
Zhang, G1
Tanaka, S1
Kobayashi, M1
Hirao, A1
Nakada, M1

Other Studies

1 other study available for 2-fluorohexadecanoic acid and Glioblastoma

ArticleYear
Identification of 2-Fluoropalmitic Acid as a Potential Therapeutic Agent Against Glioblastoma.
    Current pharmaceutical design, 2020, Volume: 26, Issue:36

    Topics: Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioblastoma; Humans; Palmitic Acids;

2020